retatrutide clinical trials efficacy (RETA) is one of the most promising investigational peptides in obesity research— Three days this week we've

This is a class effect shared across all GLP-1 receptor agonists , not a flaw in any particular medication

Crewe C, An YA, Scherer PE

The search terms used included GLP-1 agonists, Glucagon-Like Peptide-1 Receptor Agonists, semaglutide, Ozempic, Wegovy, liraglutide, bone health, orthopedic surgery, arthroplasty, post-operative complications, complications, bone health, bone strength, osteogenesis, and bone metabolism. To ensure the relevance and quality of the studies, we established specific inclusion and exclusion criteria

Despite setting expectations before patients start GLP-1s, Thiara says many still believe the drugs will enable them to reach their ideal weight